ORION BIOTECH OPPORTUNTES CO's ticker is ORIAW and the CUSIP is G6780C117. A total of 32 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $306,900 | +103.6% | 30,000 | +100.0% | 0.02% | 0.0% |
| Q4 2022 | $150,750 | +1.9% | 15,000 | 0.0% | 0.02% | +47.1% |
| Q3 2022 | $148,000 | +1.4% | 15,000 | 0.0% | 0.02% | +21.4% |
| Q2 2022 | $146,000 | 0.0% | 15,000 | 0.0% | 0.01% | +16.7% |
| Q1 2022 | $146,000 | +0.7% | 15,000 | 0.0% | 0.01% | -14.3% |
| Q4 2021 | $145,000 | -1.4% | 15,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $147,000 | – | 15,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ANGELO GORDON & CO., L.P. | 60,000 | $603,000 | 0.11% |
| GRITSTONE ASSET MANAGEMENT LLC | 276,000 | $41,869 | 0.05% |
| Anson Funds Management LP | 15,000 | $150,750 | 0.02% |
| Radcliffe Capital Management, L.P. | 80,001 | $804,010 | 0.02% |
| Segantii Capital Management Ltd | 30,000 | $302,000 | 0.01% |
| Arena Capital Advisors, LLC- CA | 111,314 | $16,886 | 0.01% |
| PERISCOPE CAPITAL INC. | 383,533 | $58,942 | 0.00% |
| 683 Capital Management, LLC | 239,800 | $36,378 | 0.00% |
| Atalaya Capital Management LP | 100,000 | $15,000 | 0.00% |
| Kepos Capital LP | 80,000 | $12 | 0.00% |